Status:
COMPLETED
AI-EBUS-Elastography for LN Staging
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Artificial Intelligence
Endobronchial Ultrasound
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Before any treatment decisions are made for patients with lung cancer, it is crucial to determine whether the cancer has spread to the lymph nodes in the chest. Traditionally, this is determined by ta...
Eligibility Criteria
Inclusion
- Patients that are diagnosed with suspected or confirmed NSCLC that have been referred to mediastinal staging through EBUS-TBNA at St. Joseph's Healthcare Hamilton will be eligible for this study.
Exclusion
- No exclusion criteria will apply.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04816981
Start Date
September 1 2021
End Date
May 1 2022
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6